I

n a victory for the pharmaceutical industry, a federal appeals court panel ruled that a Maryland state law that was enacted to punish generic drug makers for price gouging is unconstitutional.

In explaining its decision, the panel sided with a trade group for generic drug makers that argued the state law violates interstate commerce by giving Maryland officials the right to govern business outside the state, effectively providing “unprecedented powers to regulate the national pharmaceutical market.”

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.